Literature DB >> 23974684

Allergic conjunctivitis: an update on diagnosis and management.

Terrence P O'Brien1.   

Abstract

PURPOSE OF REVIEW: The focus of this review is to provide a logical paradigm for the diagnosis and treatment of ocular allergies, with a focus on seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC). RECENT
FINDINGS: Several classes of topical medications are currently available for the management of ocular allergies, including: lubricating agents, vasoconstrictors, antihistamines, mast cell stabilizers, and topical corticosteroids.
SUMMARY: SAC and PAC make up the vast majority of ocular allergy cases. A proactive approach to these diseases, anticipating the regional spring and fall allergen spikes, is needed for optimally managing these disorders. A multifaceted treatment regimen comprising patient education, lifestyle modification, and topical medications (such as antihistamines and/or mast cell stabilizers and corticosteroids) may be required in order to manage ocular allergies effectively. The appropriate treatment paradigm is based on the severity of the patients' signs and symptoms. For moderate-to-severe cases, especially chronic vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis, comanagement with an ophthalmologist is recommended.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974684     DOI: 10.1097/ACI.0b013e328364ec3a

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  12 in total

1.  Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.

Authors:  Fang-Yu Liu; Hsin-Yu Liu; Hsiao-Sang Chu; Wei-Li Chen; Fung-Rong Hu; I-Jong Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-09       Impact factor: 3.117

Review 2.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

3.  Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis.

Authors:  Chuan-Hui Kuo; Andrea M Collins; Douglas R Boettner; YanFen Yang; Santa J Ono
Journal:  J Immunol       Date:  2016-12-12       Impact factor: 5.422

Review 4.  [Seasonal allergic conjunctivitis].

Authors:  K Schröder; D Finis; S Meller; M Wagenmann; G Geerling; U Pleyer
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

5.  Prevalence of allergic conjunctivitis among basic school children in the Kumasi Metropolis (Ghana): a community-based cross-sectional study.

Authors:  David Ben Kumah; Seth Yaw Lartey; Felix Yemanyi; Evans Gyimah Boateng; Emmanuel Awuah
Journal:  BMC Ophthalmol       Date:  2015-07-03       Impact factor: 2.209

6.  Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.

Authors:  Atsuki Fukushima; Nobuyuki Ebihara
Journal:  Adv Ther       Date:  2014-10-01       Impact factor: 3.845

Review 7.  Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.

Authors:  Maria Teresa Ventura; Nicola Scichilone; Roberto Paganelli; Paola Lucia Minciullo; Vincenzo Patella; Matteo Bonini; Giovanni Passalacqua; Carlo Lombardi; Livio Simioni; Erminia Ridolo; Stefano R Del Giacco; Sebastiano Gangemi; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2017-02-03

8.  Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.

Authors:  Warner Carr; Jack Schaeffer; Eric Donnenfeld
Journal:  Allergy Rhinol (Providence)       Date:  2016-07-26

Review 9.  A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management.

Authors:  Elizabeth Yeu; Scott Hauswirth
Journal:  Clin Ophthalmol       Date:  2020-03-12

10.  The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review.

Authors:  Yingxin Zi; Yu Deng; Meiqi Ji; Yali Qin; Luqi Nong; Ziqiang Liu; Ming Jin
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.